# FL genes

## Origins of FL genes![sankey](FL_sankey-1.svg)

## Tier 1 FL genes

|          Gene          | Tier |                         Relevant references                         |
|:----------------------:|:----:|:-------------------------------------------------------------------:|
|      [ACTB](ACTB)      |  1   |                         (Lohr et al. 2012)                          |
|    [ARID1A](ARID1A)    |  1   |     (Zhang et al. 2013; Love et al. 2012; Krysiak et al. 2017)      |
|   [ATP6AP1](ATP6AP1)   |  1   |                        (Okosun et al. 2016)                         |
|  [ATP6V1B2](ATP6V1B2)  |  1   |                        (Okosun et al. 2016)                         |
|       [B2M](B2M)       |  1   |                         (Morin et al. 2011)                         |
|      [BCL2](BCL2)      |  1   |   (Tanaka et al. 1992; Morin et al. 2011; Burkhardt et al. 2022)    |
|      [BCL6](BCL6)      |  1   |                (Morin et al. 2011; Love et al. 2012)                |
|     [BCL7A](BCL7A)     |  1   |    (Grande et al. 2019; Krysiak et al. 2017; Arthur et al. 2018)    |
|     [BIRC6](BIRC6)     |  1   |                         (Reddy et al. 2017)                         |
|      [BTG1](BTG1)      |  1   |             (Burkhardt et al. 2022; Morin et al. 2011)              |
|      [BTG2](BTG2)      |  1   |                (Love et al. 2012; Morin et al. 2011)                |
|       [BTK](BTK)       |  1   |           (Krysiak et al. 2017; Albuquerque et al. 2017)            |
|    [CARD11](CARD11)    |  1   |      (Panea et al. 2019; Morin et al. 2011; Lenz et al. 2008)       |
|     [CCND3](CCND3)     |  1   |              (Richter et al. 2012; Morin et al. 2011)               |
|      [CD83](CD83)      |  1   | (Panea et al. 2019; Russler-Germain et al. 2023; Morin et al. 2013) |
|    [CREBBP](CREBBP)    |  1   | (Love et al. 2012; Laura Pasqualucci, Dominguez-Sola, et al. 2011)  |
|      [CTSS](CTSS)      |  1   |                        (Bararia et al. 2020)                        |
|      [DTX1](DTX1)      |  1   |              (Panea et al. 2019; Schmitz et al. 2018)               |
|      [EBF1](EBF1)      |  1   |               (Bohle et al. 2013; Thomas et al. 2023)               |
|    [EEF1A1](EEF1A1)    |  1   |                      (Hübschmann et al. 2021)                       |
|     [EP300](EP300)     |  1   | (Laura Pasqualucci, Dominguez-Sola, et al. 2011; Panea et al. 2019) |
|      [EZH2](EZH2)      |  1   |                (Love et al. 2012; Morin et al. 2010)                |
|       [FAS](FAS)       |  1   |                        (Scholl et al. 2007)                         |
|     [FOXO1](FOXO1)     |  1   |              (Schmitz et al. 2012; Morin et al. 2011)               |
|     [GNA13](GNA13)     |  1   |                (Morin et al. 2011; Love et al. 2012)                |
|     [GNAI2](GNAI2)     |  1   |               (Grande et al. 2019; Morin et al. 2013)               |
|  [HIST1H1B](HIST1H1B)  |  1   |              (Krysiak et al. 2017; Chapuy et al. 2018)              |
|  [HIST1H1C](HIST1H1C)  |  1   |               (Morin et al. 2011; Panea et al. 2019)                |
|  [HIST1H1D](HIST1H1D)  |  1   |              (Morin et al. 2013; Krysiak et al. 2017)               |
|  [HIST1H1E](HIST1H1E)  |  1   |    (Krysiak et al. 2017; Grande et al. 2019; Morin et al. 2013)     |
| [HIST1H2AC](HIST1H2AC) |  1   |              (Krysiak et al. 2017; Morin et al. 2013)               |
| [HIST1H2AG](HIST1H2AG) |  1   |     (Panea et al. 2019; Krysiak et al. 2017; Morin et al. 2013)     |
| [HIST1H2AM](HIST1H2AM) |  1   |              (Krysiak et al. 2017; Panea et al. 2019)               |
| [HIST1H2BC](HIST1H2BC) |  1   |              (Reddy et al. 2017; Krysiak et al. 2017)               |
| [HIST1H2BD](HIST1H2BD) |  1   |                        (Krysiak et al. 2017)                        |
| [HIST1H2BG](HIST1H2BG) |  1   |                        (Krysiak et al. 2017)                        |
|  [HIST1H3B](HIST1H3B)  |  1   |                         (Zhang et al. 2013)                         |
|  [HIST1H3G](HIST1H3G)  |  1   |                        (Krysiak et al. 2017)                        |
|     [HVCN1](HVCN1)     |  1   |                        (Krysiak et al. 2017)                        |
|      [IRF4](IRF4)      |  1   |                         (Morin et al. 2011)                         |
|      [IRF8](IRF8)      |  1   |               (Morin et al. 2011; Panea et al. 2019)                |
|     [ITPKB](ITPKB)     |  1   |                        (Schmitz et al. 2018)                        |
|      [KLF2](KLF2)      |  1   |             (Laura Pasqualucci, Trifonov, et al. 2011)              |
|     [KLHL6](KLHL6)     |  1   |               (Morin et al. 2011; Panea et al. 2019)                |
|     [KMT2D](KMT2D)     |  1   |               (Grande et al. 2019; Morin et al. 2011)               |
|       [LTB](LTB)       |  1   |               (Chapuy et al. 2018; Panea et al. 2019)               |
|    [MAP2K1](MAP2K1)    |  1   |             (Louissaint et al. 2016; Shin et al. 2015)              |
|     [MEF2B](MEF2B)     |  1   |                         (Morin et al. 2011)                         |
|     [MEF2C](MEF2C)     |  1   |                        (Arthur et al. 2018)                         |
|      [PCLO](PCLO)      |  1   |                         (Lohr et al. 2012)                          |
|      [PIM1](PIM1)      |  1   |         (L. Pasqualucci et al. 2001; Burkhardt et al. 2022)         |
|   [POU2AF1](POU2AF1)   |  1   |                        (Krysiak et al. 2017)                        |
|    [POU2F2](POU2F2)    |  1   |              (Zhang et al. 2013; Krysiak et al. 2017)               |
|     [PTPRD](PTPRD)     |  1   |                                \[\]                                 |
|     [RRAGC](RRAGC)     |  1   |                        (Okosun et al. 2016)                         |
|     [S1PR2](S1PR2)     |  1   |              (Morin et al. 2011; Muppidi et al. 2014)               |
|      [SGK1](SGK1)      |  1   |                         (Morin et al. 2011)                         |
|   [SMARCA4](SMARCA4)   |  1   |    (Zhang et al. 2013; Krysiak et al. 2017; Richter et al. 2012)    |
|     [SOCS1](SOCS1)     |  1   |                         (Morin et al. 2011)                         |
|     [STAT6](STAT6)     |  1   |                        (Yildiz et al. 2015)                         |
|   [TBL1XR1](TBL1XR1)   |  1   |                       (Mareschal et al. 2016)                       |
|    [TMSB4X](TMSB4X)    |  1   |                      (Albuquerque et al. 2017)                      |
|   [TNFAIP3](TNFAIP3)   |  1   |                       (Compagno et al. 2009)                        |
|  [TNFRSF14](TNFRSF14)  |  1   |                        (Cheung et al. 2010)                         |
|      [TP53](TP53)      |  1   |               (Wilda et al. 2004; Morin et al. 2011)                |
|     [VMA21](VMA21)     |  1   |                      (Hübschmann et al. 2021)                       |

## Tier 2 FL genes

|          Gene          | Tier |                        Relevant references                         |
|:----------------------:|:----:|:------------------------------------------------------------------:|
|      [ABL2](ABL2)      |  2   |                   (Russler-Germain et al. 2023)                    |
|     [ACTG1](ACTG1)     |  2   |                      (Hübschmann et al. 2021)                      |
|   [ATP6V1A](ATP6V1A)   |  2   |                      (Hübschmann et al. 2021)                      |
|     [BCL10](BCL10)     |  2   |          (Russler-Germain et al. 2023; Morin et al. 2011)          |
| [CCDC42BPB](CCDC42BPB) |  2   |                      (Hübschmann et al. 2021)                      |
|      [CD70](CD70)      |  2   |          (Russler-Germain et al. 2023; Morin et al. 2011)          |
|     [CD79B](CD79B)     |  2   |               (Panea et al. 2019; Morin et al. 2011)               |
|      [CILP](CILP)      |  2   |                   (Russler-Germain et al. 2023)                    |
|     [CPNE8](CPNE8)     |  2   |                      (Hübschmann et al. 2021)                      |
|     [CXCR4](CXCR4)     |  2   | (Panea et al. 2019; Krysiak et al. 2017; Khodabakhshi et al. 2012) |
|    [CYP2A6](CYP2A6)    |  2   |                   (Russler-Germain et al. 2023)                    |
|     [DDX3X](DDX3X)     |  2   |                    (Schmitz et al. 2012, 2018)                     |
|     [DHX15](DHX15)     |  2   |                      (Hübschmann et al. 2021)                      |
|     [DUSP2](DUSP2)     |  2   |                        (Morin et al. 2013)                         |
|      [EGR1](EGR1)      |  2   |                       (Krysiak et al. 2017)                        |
|      [FZR1](FZR1)      |  2   |                      (Hübschmann et al. 2021)                      |
|      [GBP7](GBP7)      |  2   |                   (Russler-Germain et al. 2023)                    |
|      [GRM6](GRM6)      |  2   |                   (Russler-Germain et al. 2023)                    |
| [HIST1H2BM](HIST1H2BM) |  2   |                       (Krysiak et al. 2017)                        |
|  [HIST1H3I](HIST1H3I)  |  2   |              (Krysiak et al. 2017; Panea et al. 2019)              |
|     [HLA-B](HLA-B)     |  2   |                                \[\]                                |
|    [HNRNPD](HNRNPD)    |  2   |                                \[\]                                |
|     [IGLL5](IGLL5)     |  2   |          (Panea et al. 2019; Russler-Germain et al. 2023)          |
|       [JUP](JUP)       |  2   |                      (Hübschmann et al. 2021)                      |
|   [KIR3DL1](KIR3DL1)   |  2   |                   (Russler-Germain et al. 2023)                    |
|    [LAPTM5](LAPTM5)    |  2   |                      (Hübschmann et al. 2021)                      |
|    [MAGEC1](MAGEC1)    |  2   |                   (Russler-Germain et al. 2023)                    |
|    [MAP7D1](MAP7D1)    |  2   |                   (Russler-Germain et al. 2023)                    |
|     [MGEA5](MGEA5)     |  2   |                      (Hübschmann et al. 2021)                      |
|     [MKI67](MKI67)     |  2   |         (Russler-Germain et al. 2023; Schmitz et al. 2012)         |
|       [MYC](MYC)       |  2   |      (Johnston and Carroll 1992; L. Pasqualucci et al. 2001)       |
|    [MYCBP2](MYCBP2)    |  2   |                      (Hübschmann et al. 2021)                      |
|     [MYD88](MYD88)     |  2   |                         (Ngo et al. 2011)                          |
|    [NFKBIA](NFKBIA)    |  2   |          (Russler-Germain et al. 2023; Lake et al. 2009)           |
|     [OR8H2](OR8H2)     |  2   |                   (Russler-Germain et al. 2023)                    |
|     [P2RY8](P2RY8)     |  2   |              (Lohr et al. 2012; Muppidi et al. 2014)               |
|     [PDS5B](PDS5B)     |  2   |            (Morin et al. 2013; Hübschmann et al. 2021)             |
|     [PPP4C](PPP4C)     |  2   |                      (Hübschmann et al. 2021)                      |
|     [PRKDC](PRKDC)     |  2   |           (Hübschmann et al. 2021; Schmitz et al. 2018)            |
|       [PZP](PZP)       |  2   |                   (Russler-Germain et al. 2023)                    |
|      [RBM6](RBM6)      |  2   |                      (Hübschmann et al. 2021)                      |
|     [SESN1](SESN1)     |  2   |                       (Oricchio et al. 2017)                       |
|   [SHROOM3](SHROOM3)   |  2   |                   (Russler-Germain et al. 2023)                    |
|     [SRRM2](SRRM2)     |  2   |          (Russler-Germain et al. 2023; Morin et al. 2013)          |
|     [STAB2](STAB2)     |  2   |                   (Russler-Germain et al. 2023)                    |
|   [TMEM30A](TMEM30A)   |  2   |                        (Morin et al. 2011)                         |
|      [TPP1](TPP1)      |  2   |                      (Hübschmann et al. 2021)                      |
|     [XIRP2](XIRP2)     |  2   |                   (Russler-Germain et al. 2023)                    |
|   [ZC3H12A](ZC3H12A)   |  2   |                        (Arthur et al. 2018)                        |
|    [ZNF608](ZNF608)    |  2   |              (Krysiak et al. 2017; Zhang et al. 2013)              |

# References

<div id="refs" class="references csl-bib-body hanging-indent">

<div id="ref-albuquerqueEnhancingKnowledgeDiscovery2017a"
class="csl-entry">

Albuquerque, Marco A., Bruno M. Grande, Elie J. Ritch, Prasath
Pararajalingam, Selin Jessa, Martin Krzywinski, Jasleen K. Grewal,
Sohrab P. Shah, Paul C. Boutros, and Ryan D. Morin. 2017. “Enhancing
Knowledge Discovery from Cancer Genomics Data with Galaxy.”
*GigaScience* 6 (5): 1–13. <https://doi.org/10.1093/gigascience/gix015>.

</div>

<div id="ref-arthurGenomewideDiscoverySomatic2018" class="csl-entry">

Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan
Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide
Discovery of Somatic Regulatory Variants in Diffuse Large <span
class="nocase">B-cell</span> Lymphoma.” *Nature Communications* 9 (1):
4001. <https://doi.org/10.1038/s41467-018-06354-3>.

</div>

<div id="ref-barariaCathepsinAlterationsInduce2020c" class="csl-entry">

Bararia, Deepak, Johannes A. Hildebrand, Sebastian Stolz, Sarah Haebe,
Stefan Alig, Christopher P. Trevisani, Francisco Osorio-Barrios, et al.
2020. “Cathepsin S Alterations Induce a Tumor-Promoting Immune
Microenvironment in Follicular Lymphoma.” *Cell Reports* 31 (5): 107522.
<https://doi.org/10.1016/j.celrep.2020.107522>.

</div>

<div id="ref-bohleRoleEarlyBcell2013" class="csl-entry">

Bohle, V., C. Döring, M.-L. Hansmann, and R. Küppers. 2013. “Role of
Early <span class="nocase">B-cell</span> Factor 1 (EBF1) in Hodgkin
Lymphoma.” *Leukemia* 27 (3): 671–79.
<https://doi.org/10.1038/leu.2012.280>.

</div>

<div id="ref-burkhardtClinicalRelevanceMolecular2022b"
class="csl-entry">

Burkhardt, Birgit, Ulf Michgehl, Jonas Rohde, Tabea Erdmann, Philipp
Berning, Katrin Reutter, Marius Rohde, et al. 2022. “Clinical Relevance
of Molecular Characteristics in Burkitt Lymphoma Differs According to
Age.” *Nature Communications* 13 (1): 3881.
<https://doi.org/10.1038/s41467-022-31355-8>.

</div>

<div id="ref-chapuyMolecularSubtypesDiffuse2018b" class="csl-entry">

Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas
Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular
Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct
Pathogenic Mechanisms and Outcomes.” *Nature Medicine* 24 (5): 679–90.
<https://doi.org/10.1038/s41591-018-0016-8>.

</div>

<div id="ref-cheungAcquiredTNFRSF14Mutations2010a" class="csl-entry">

Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa
Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al.
2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated
with Worse Prognosis.” *Cancer Research* 70 (22): 9166–74.
<https://doi.org/10.1158/0008-5472.CAN-10-2460>.

</div>

<div id="ref-compagnoMutationsMultipleGenes2009a" class="csl-entry">

Compagno, Mara, Wei Keat Lim, Adina Grunn, Subhadra V. Nandula, Manisha
Brahmachary, Qiong Shen, Francesco Bertoni, et al. 2009. “Mutations of
Multiple Genes Cause Deregulation of <span
class="nocase">NF-kappaB</span> in Diffuse Large <span
class="nocase">B-cell</span> Lymphoma.” *Nature* 459 (7247): 717–21.
<https://doi.org/10.1038/nature07968>.

</div>

<div id="ref-grandeGenomewideDiscoverySomatic2019" class="csl-entry">

Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner,
Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, et al. 2019.
“Genome-Wide Discovery of Somatic Coding and Noncoding Mutations in
Pediatric Endemic and Sporadic Burkitt Lymphoma.” *Blood* 133 (12):
1313–24. <https://doi.org/10.1182/blood-2018-09-871418>.

</div>

<div id="ref-hubschmannMutationalMechanismsShaping2021b"
class="csl-entry">

Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H.
Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al.
2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of
Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.”
*Leukemia* 35 (7): 2002–16.
<https://doi.org/10.1038/s41375-021-01251-z>.

</div>

<div id="ref-johnstonCmycHypermutationBurkitt1992" class="csl-entry">

Johnston, J. M., and W. L. Carroll. 1992. “C-Myc Hypermutation in
Burkitt’s Lymphoma.” *Leukemia & Lymphoma* 8 (6): 431–39.
<https://doi.org/10.3109/10428199209051025>.

</div>

<div id="ref-khodabakhshiRecurrentTargetsAberrant2012"
class="csl-entry">

Khodabakhshi, Alireza Hadj, Ryan D. Morin, Anthony P. Fejes, Andrew J.
Mungall, Karen L. Mungall, Madison Bolger-Munro, Nathalie A. Johnson, et
al. 2012. “Recurrent Targets of Aberrant Somatic Hypermutation in
Lymphoma.” *Oncotarget* 3 (11): 1308–19.
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717795/>.

</div>

<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry">

Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock,
Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017.
“Recurrent Somatic Mutations Affecting <span
class="nocase">B-cell</span> Receptor Signaling Pathway Genes in
Follicular Lymphoma.” *Blood* 129 (4): 473–83.
<https://doi.org/10.1182/blood-2016-07-729954>.

</div>

<div id="ref-lakeMutationsNFKBIAEncoding2009" class="csl-entry">

Lake, Annette, Lesley A. Shield, Pablo Cordano, Daniel T. Y. Chui, Julie
Osborne, Shauna Crae, Katherine S. Wilson, et al. 2009. “Mutations of
NFKBIA, Encoding IkappaB Alpha, Are a Recurrent Finding in Classical
Hodgkin Lymphoma but Are Not a Unifying Feature of Non-<span
class="nocase">EBV-associated</span> Cases.” *International Journal of
Cancer* 125 (6): 1334–42. <https://doi.org/10.1002/ijc.24502>.

</div>

<div id="ref-lenzOncogenicCARD11Mutations2008" class="csl-entry">

Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George,
George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11
Mutations in Human Diffuse Large B Cell Lymphoma.” *Science* 319 (5870):
1676–79.

</div>

<div id="ref-lohrDiscoveryPrioritizationSomatic2012a" class="csl-entry">

Lohr, Jens G., Petar Stojanov, Michael S. Lawrence, Daniel Auclair,
Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, et al. 2012.
“Discovery and Prioritization of Somatic Mutations in Diffuse Large
<span class="nocase">B-cell</span> Lymphoma (DLBCL) by Whole-Exome
Sequencing.” *Proceedings of the National Academy of Sciences of the
United States of America* 109 (10): 3879–84.
<https://doi.org/10.1073/pnas.1121343109>.

</div>

<div id="ref-louissaintPediatrictypeNodalFollicular2016a"
class="csl-entry">

Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E.
Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016.
“Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct
Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 (8):
1093–1100. <https://doi.org/10.1182/blood-2015-12-682591>.

</div>

<div id="ref-loveGeneticLandscapeMutations2012" class="csl-entry">

Love, Cassandra, Zhen Sun, Dereje Jima, Guojie Li, Jenny Zhang, Rodney
Miles, Kristy L. Richards, et al. 2012. “The Genetic Landscape of
Mutations in Burkitt Lymphoma.” *Nature Genetics* 44 (12): 1321–25.
<https://doi.org/10.1038/ng.2468>.

</div>

<div id="ref-mareschalWholeExomeSequencing2016" class="csl-entry">

Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe
Bertrand, Elodie Bohers, Catherine Maingonnat, Jean-Philippe Jaïs, et
al. 2016. “Whole Exome Sequencing of Relapsed/Refractory Patients
Expands the Repertoire of Somatic Mutations in Diffuse Large <span
class="nocase">B-cell</span> Lymphoma.” *Genes, Chromosomes & Cancer* 55
(3): 251–67. <https://doi.org/10.1002/gcc.22328>.

</div>

<div id="ref-morinSomaticMutationsAltering2010a" class="csl-entry">

Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J.
Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010.
“Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse
Large <span class="nocase">B-cell</span> Lymphomas of Germinal-Center
Origin.” *Nature Genetics* 42 (2): 181–85.
<https://doi.org/10.1038/ng.518>.

</div>

<div id="ref-morinFrequentMutationHistonemodifying2011"
class="csl-entry">

Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya,
Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011.
“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.”
*Nature* 476 (7360): 298–303. <https://doi.org/10.1038/nature10351>.

</div>

<div id="ref-morinMutationalStructuralAnalysis2013" class="csl-entry">

Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall,
Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and
Structural Analysis of Diffuse Large <span class="nocase">B-cell</span>
Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 (7): 1256–65.
<https://doi.org/10.1182/blood-2013-02-483727>.

</div>

<div id="ref-muppidiLossSignalingGa132014b" class="csl-entry">

Muppidi, J., R. Schmitz, Jesse A. Green, Jesse A. Green, Wenming Xiao,
Adrien B. Larsen, S. Braun, et al. 2014. “Loss of Signaling via Gα13 in
Germinal Center B Cell-Derived Lymphoma.” *Nature* 516: 254–58.
<https://doi.org/10.1038/nature13765>.

</div>

<div id="ref-ngoOncogenicallyActiveMYD882011a" class="csl-entry">

Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao,
Kian-Huat Lim, Holger Kohlhammer, et al. 2011. “Oncogenically Active
MYD88 Mutations in Human Lymphoma.” *Nature* 470 (7332): 115–19.
<https://doi.org/10.1038/nature09671>.

</div>

<div id="ref-okosunRecurrentMTORC1activatingRRAGC2016a"
class="csl-entry">

Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy
Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016.
“Recurrent <span class="nocase">mTORC1-activating RRAGC</span> Mutations
in Follicular Lymphoma.” *Nature Genetics* 48 (2): 183–88.
<https://doi.org/10.1038/ng.3473>.

</div>

<div id="ref-oricchioGeneticEpigeneticInactivation2017b"
class="csl-entry">

Oricchio, Elisa, Natalya Katanayeva, Maria Christine Donaldson,
Stephanie Sungalee, Joyce P. Pasion, Wendy Béguelin, Elena Battistello,
et al. 2017. “Genetic and Epigenetic Inactivation of SESTRIN1 Controls
<span class="nocase">mTORC1</span> and Response to EZH2 Inhibition in
Follicular Lymphoma.” *Science Translational Medicine* 9 (396):
eaak9969. <https://doi.org/10.1126/scitranslmed.aak9969>.

</div>

<div id="ref-paneaWholeGenomeLandscape2019" class="csl-entry">

Panea, R., C. Love, Jennifer R. Shingleton, Anupama Reddy, J. Bailey, A.
Moormann, J. Otieno, et al. 2019. “The Whole Genome Landscape of Burkitt
Lymphoma Subtypes.” *Blood*. <https://doi.org/10.1182/blood.2019001880>.

</div>

<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a"
class="csl-entry">

Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia
Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011.
“Inactivating Mutations of Acetyltransferase Genes in <span
class="nocase">B-cell</span> Lymphoma.” *Nature* 471 (7337): 189–95.
<https://doi.org/10.1038/nature09730>.

</div>

<div id="ref-pasqualucciAnalysisCodingGenome2011" class="csl-entry">

Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide
Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of
the Coding Genome of Diffuse Large <span class="nocase">B-cell</span>
Lymphoma.” *Nature Genetics* 43 (9): 830–37.
<https://doi.org/10.1038/ng.892>.

</div>

<div id="ref-pasqualucciHypermutationMultipleProtooncogenes2001a"
class="csl-entry">

Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S.
Chaganti, R. Küppers, and R. Dalla-Favera. 2001. “Hypermutation of
Multiple Proto-Oncogenes in <span class="nocase">B-cell</span> Diffuse
Large-Cell Lymphomas.” *Nature* 412 (6844): 341–46.
<https://doi.org/10.1038/35085588>.

</div>

<div id="ref-reddyGeneticFunctionalDrivers2017" class="csl-entry">

Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt,
Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic
and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171
(2): 481–494.e15.

</div>

<div id="ref-richterRecurrentMutationID32012a" class="csl-entry">

Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen
Leich, Birgit Burkhardt, Maciej Rosolowski, et al. 2012. “Recurrent
Mutation of the ID3 Gene in Burkitt Lymphoma Identified by Integrated
Genome, Exome and Transcriptome Sequencing.” *Nature Genetics* 44 (12):
1316–20. <https://doi.org/10.1038/ng.2469>.

</div>

<div id="ref-russler-germainMutationsAssociatedProgression2023b"
class="csl-entry">

Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew
Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al.
2023. “Mutations Associated with Progression in Follicular Lymphoma
Predict Inferior Outcomes at Diagnosis: Alliance A151303.” *Blood
Advances* 7: 5524–39.
<https://doi.org/10.1182/bloodadvances.2023010779>.

</div>

<div id="ref-schmitzGeneticsPathogenesisDiffuse2018a" class="csl-entry">

Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson,
James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018.
“Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.” *The New
England Journal of Medicine* 378 (15): 1396–1407.
<https://doi.org/10.1056/NEJMoa1801445>.

</div>

<div id="ref-schmitzBurkittLymphomaPathogenesis2012" class="csl-entry">

Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar,
Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma
Pathogenesis and Therapeutic Targets from Structural and Functional
Genomics.” *Nature* 490 (7418): 116–20.
<https://doi.org/10.1038/nature11378>.

</div>

<div id="ref-schollMutationsRegionFAS2007" class="csl-entry">

Scholl, Vanesa, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector,
and Ilana Zalcberg Renault. 2007. “Mutations Within the 5’ Region of
FAS/CD95 Gene in Nodal Diffuse Large <span class="nocase">B-cell</span>
Lymphoma.” *Leukemia & Lymphoma* 48 (5): 957–63.
<https://doi.org/10.1080/10428190701230858>.

</div>

<div id="ref-shinBRAFV600EMAP2K12015" class="csl-entry">

Shin, Sang-Yong, Seung-Tae Lee, Hee-Jin Kim, Chang-Seok Ki, Chul Won
Jung, Jong-Won Kim, and Sun-Hee Kim. 2015. “BRAF V600E and MAP2K1
Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma
Cases.” *Annals of Laboratory Medicine* 35 (2): 257–59.
<https://doi.org/10.3343/alm.2015.35.2.257>.

</div>

<div id="ref-tanakaFrequentIncidenceSomatic1992" class="csl-entry">

Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent
Incidence of Somatic Mutations in Translocated BCL2 Oncogenes of
Non-Hodgkin’s Lymphomas.” *Blood* 79 (1): 229–37.

</div>

<div id="ref-thomasGeneticSubgroupsInform2023" class="csl-entry">

Thomas, Nicole, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton,
Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, et al. 2023.
“Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt
Lymphoma.” *Blood* 141 (8): 904–16.
<https://doi.org/10.1182/blood.2022016534>.

</div>

<div id="ref-wildaInactivationARFMDM2p53Pathway2004" class="csl-entry">

Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and
W. Woessmann. 2004. “Inactivation of the <span
class="nocase">ARF-MDM-2-p53</span> Pathway in Sporadic Burkitt’s
Lymphoma in Children.” *Leukemia* 18 (3): 584–88.
<https://doi.org/10.1038/sj.leu.2403254>.

</div>

<div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry">

Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter
Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6
Mutations in Follicular Lymphoma.” *Blood* 125 (4): 668–79.
<https://doi.org/10.1182/blood-2014-06-582650>.

</div>

<div id="ref-zhangGeneticHeterogeneityDiffuse2013" class="csl-entry">

Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee,
Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013.
“Genetic Heterogeneity of Diffuse Large <span
class="nocase">B-cell</span> Lymphoma.” January.

</div>

</div>
